QT Imaging, Selects Freedom Ventures B.V., As the Exclusive Distributor of Its 3D Breast Imaging Technology in the EMEA Markets

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

January 7, 2021

QT Imaging notes Freedom Ventures, is a Dutch company that will do business as QT Scan BV, is well established in the field of medical devices, with an extensive network of distributors, and a Center of Excellence for technical, marketing, and clinical training.

“As a small company, working with an established distribution network provides our global market reach while being able to maintain the level of quality in marketing, sales, technical service, and most importantly patient care, that we have established in the US. Freedom Ventures has the experience to be that partner in this important region,” says Meg Donigan, Chief Operating Officer at QT Imaging.  Freedom Ventures will also assist QT Imaging in securing a CE Mark and manage the registration process in its markets.

QT Imaging, QTscan®The European medical imaging market, currently valued at $38 Billion, is expected to grow almost 10% annually over the next decade, with advancements in medical imaging technology driving that increased demand.

QT’s medical imaging technology generates 3D images with remarkable accuracy and precision, and the volumetric images are produced without the need of contrast injections or radiation.  The QTscan® is an FDA-cleared breast imaging tool, and the company will seek CE marking to provide confidence to the healthcare community that the device meets EU safety, health, and environmental protection requirements before market launch.

Rutger Brest van Kempen, CEO of Freedom Ventures, says “We’re very excited about the opportunity the radiation-free QTscan has to fill a unique need in the European breast imaging market where women are being screened later and less frequently due to concerns about radiation. In the Middle East and North Africa, this new technology will also be embraced for its ease of adoption as it requires no costly facilities or special licensing for operators.

Hisham Hasaan, Freedom Ventures Vice-President for the Middle East and Africa says, “With QTscan we will have a huge opportunity to screen woman, who now have to travel far to hospitals where radiology equipment is available whereas our technologies can be installed virtually anywhere. We will focus on creating regional QTscan centers to bring this unique technology to the masses.”

Note: QT Imaging Completed Its In Class and 1st In Human Study: Quantitative Transmission Ultrasound Research Shows Better Performance Than Mammography



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.